NEW IMPERIAL LINE (OPHTHALMOLOGY, PERFECT DROP CONTROL, DRY EYE)
Product Description
NTC S.r.l.
.jpg)
-
Country/Region:Italy
-
On CPHI since:2015
-
Certificates:3
-
Employees:100 - 249
Company types
Primary activities
Categories
Specifications
NTC S.r.l.
-
Country/Region:Italy
-
On CPHI since:2015
-
Certificates:3
-
Employees:100 - 249
Company types
Primary activities
More Products from NTC S.r.l. (2)
-
Product PROTECTORIAL/PURO PROTECT - Isotonic ointment with Hyaluronic Acid 0.4% (Ophthalmology - Dry Eye)
First in class ointment in the market enriched with Hyaluronic Acid. This product, thanks to Hyaluronic Acid and its isotonic characteristic, has been specifically formulated to offer effective symptoms relief for patients suffering from moderate to severe dry eye, kerato-conjunctivitis sicca and noct... -
Product PURO EPITHEL - Carbomer + Dexpanthenol (Ophthalmology - Dry Eye)
Specifically formulated to offer effective symptoms relief for patients suffering from dry eye syndrome and to stimulate epithelial corneal reparation in case of corneal erosion, burns, after ocular surgery (cataract and refractive) and in prolonged use of contact lenses .
Ophthalmic gel...
NTC S.r.l. resources (2)
-
News A pharmacovigilance study published confirms the safety of fixed-dose eye drops for post-cataract surgery
A pharmacovigilance study published confirms the safety of fixed-dose eye drops for post-cataract surgery 17 Jul, 2025A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination eye drop containing an anti-inflammatory steroid and a quinolone antibiotic, developed by NTC, indicated for the prevention and treatment of inflammation and prevention of infection following cataract surgery in adults. The study was submitted when nearly 4 million patients across about 60 countries worldwide were treated with this drug.
